The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Synthetic Nanoparticles for Vaccines and Immunotherapy
Open accessAbstract
The immune system plays a critical role in our health. No other component of human physiology plays a decisive role in as diverse an array of maladies, from deadly diseases with which we are all familiar to equally terrible esoteric conditions: HIV, malaria, pneumococcal and influenza infections; cancer; atherosclerosis; autoimmune diseases such as lupus, diabetes, and multiple sclerosis. The importance of understanding the function of the immune system and learning how to modulate immunity to protect against or treat disease thus cannot be overstated. Fortunately, we are entering an exciting era where the science of immunology is defining pathways for the rational manipulation of the immune system at the cellular and molecular level, and this understanding is leading to dramatic advances in the clinic that are transforming the future of medicine.1,2 These initial advances are being made primarily through biologic drugs– recombinant proteins (especially antibodies) or patient-derived cell therapies– but exciting data from preclinical studies suggest that a marriage of approaches based in biotechnology with the materials science and chemistry of nanomaterials, especially nanoparticles, could enable more effective and safer immune engineering strategies. This review will examine these nanoparticle-based strategies to immune modulation in detail, and discuss the promise and outstanding challenges facing the field of immune engineering from a chemical biology/materials engineering perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–331 of 331
Bertholon, I., Vauthier, C., & Labarre, D. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0069-0 · Cited by 169
Laroui, H., Viennois, E., Xiao, B., Canup, B. S. B., Geem, D., Denning, T. L., & Merlin, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.046 · Cited by 163
MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
Tsai, S., & Santamaria, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00321 · Cited by 162
Toll-like receptors and innate immunity in B-cell activation and antibody responses
Lanzavecchia, A., & Sallusto, F. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.002 · Cited by 162
“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells
Elamanchili, P., Lutsiak, C. M. E., Hamdy, S. I., Diwan, M., & Samuel, J. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802cf3e3 · Cited by 160
TLRs Regulate the Gatekeeping Functions of the Intestinal Follicle-Associated Epithelium
Chabot, S., Wagner, J. S., Farrant, S., & Neutra, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4275 · Cited by 158
Li, P., Luo, Z., Liu, P., Gao, N., Zhang, Y., Pan, H., Liu, L., Wang, C., Cai, L., & Ma, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.025 · Cited by 158
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination
Fievez, V., Plapied, L., des Rieux, A., Pourcelle, V., Freichels, H., Wascotte, V., Vanderhaeghen, M.-L., Jerôme, C., Vanderplasschen, A., Marchand-Brynaert, J., et al. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.04.009 · Cited by 158
Muraoka, D., Harada, N., Hayashi, T., Tahara, Y., Momose, F., Sawada, S., Mukai, S., Akiyoshi, K., & Shiku, H. (2014) · ACS Nano · doi:10.1021/nn502975r · Cited by 151
Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K.-P., Burg, G., Dummer, R., & Nestle, F. O. (2003) · Blood · doi:10.1182/blood-2002-08-2455 · Cited by 145
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Zheng, Y., Stephan, M. T., Gai, S. A., Abraham, W. D., Shearer, A., & Irvine, D. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.037 · Cited by 145
Self-citationForecasting the cytokine storm following systemic interleukin (IL)-2 administration
Panelli, M. C., White, R., Foster, M., Martin, B., Wang, E., Smith, K., & Marincola, F. M. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-17 · Cited by 139
Petersen, L. K., Ramer‐Tait, A. E., Broderick, S., Kong, C.-S., Ulery, B. D., Rajan, K., Wannemuehler, M. J., & Narasimhan, B. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.063 · Cited by 138
Ulery, B. D., Kumar, D., Ramer‐Tait, A. E., Metzger, D. W., Wannemuehler, M. J., & Narasimhan, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017642 · Cited by 137
Sokolova, V., Knuschke, T., Kovtun, A., Buer, J., Epple, M., & Westendorf, A. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.067 · Cited by 136
PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes
Locke, L. W., Mayo, M. W., Yoo, A. D., Williams, M. B., & Berr, S. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.022 · Cited by 136
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
Gupta, P. N., Khatri, K., Goyal, A. K., Mishra, N., & Vyas, S. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701637982 · Cited by 136
Klavinskis, L. S., Barnfield, C., Gao, L., & Parker, S. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.254 · Cited by 134
Demento, S. L., Bonafé, N., Cui, W., Kaech, S. M., Caplan, M. J., Fikrig, E., Ledizet, M., & Fahmy, T. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000768 · Cited by 134
Targeting the lymphatics using dendritic polymers (dendrimers)
Kaminskas, L. M., & Porter, C. J. H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.016 · Cited by 133
Keller, S., Wilson, J. T., Patilea-Vrana, G., Kern, H. B., Convertine, A. J., & Stayton, P. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.041 · Cited by 132
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Y., Booth, C. J., & Saltzman, W. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.036 · Cited by 129
Kourtis, I. C., Hirosue, S., de Titta, A., Kontos, S., Stegmann, T., Hubbell, J. A., & Swartz, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061646 · Cited by 129
Silva, A. L., Rosalia, R. A., Varypataki, E. M., Sibuea, S. M., OSSENDORP, F. A., & Jiskoot, W. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.12.059 · Cited by 128
Béduneau, A., Ma, Z., Grotepas, C. B., Kabanov, A. V., Rabinow, B. E., Gong, N., Mosley, R. L., Dou, H., Boska, M. D., & Gendelman, H. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004343 · Cited by 128
Engineering complement activation on polypropylene sulfide vaccine nanoparticles
Thomas, S. N., van der Vlies, A. J., O’Neil, C. P., Reddy, S. T., Yu, S. S., Giorgio, T. D., Swartz, M. A., & Hubbell, J. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.037 · Cited by 127
Turley, D. M., & Miller, S. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2212 · Cited by 126
Alvarez, I. B., Pasquinelli, V., Jurado, J. O., Abbate, E. H., Musella, R. M., de la Barrera, S., & García, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/654932 · Cited by 126
Sneh-Edri, H., Likhtenshtein, D., & Stepensky, D. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200198c · Cited by 125
Kim, Y., Pan, J. Y.-J., Korbel, G. A., Peperzak, V., Boes, M. L., & Ploegh, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511315103 · Cited by 125
Park, J. Y., Gao, W., Whiston, R., Strom, T. B., Metcalfe, S. M., & Fahmy, T. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100203a · Cited by 122
Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles
Stano, A., Scott, E. A., Dane, K. Y., Swartz, M. A., & Hubbell, J. A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.024 · Cited by 119
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine
Bershteyn, A., Hanson, M. C., Crespo, M. P., Moon, J. J., Li, A. V., Suh, H., & Irvine, D. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.029 · Cited by 118
Self-citationNanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice
Look, M., Stern, E., Wang, Q. A., DiPlacido, L. D., Kashgarian, M. J., Craft, J. E., & Fahmy, T. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65907 · Cited by 118
Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery
Diwan, M., Elamanchili, P., Cao, M., & Samuel, J. (2004) · Current Drug Delivery · doi:10.2174/1567201043334597 · Cited by 118
Mueller, S. N., Tian, S., & DeSimone, J. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500589c · Cited by 118
Yuba, E., Kojima, C., Harada, A., Tana, T., Watarai, S., & Kono, K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.006 · Cited by 117
Nakamura, T., Moriguchi, R., Kogure, K., Shastri, N., & Harashima, H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.122 · Cited by 115
Liposomes as Drug Delivery Systems for The Treatment of TB
Pinheiro, M., Lúcio, M., Lima, J. L. F. C., & Reis, S. (2011) · Nanomedicine · doi:10.2217/nnm.11.122 · Cited by 114
Ahn, S., Lee, I., Kang, S., Kim, D., Choi, M., Saw, P. E., Shin, E., & Jon, S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300597 · Cited by 114
Hanlon, D. J., Saluja, S. S., Sharp, F. A., Hong, E., Khalil, D., Tigelaar, R. E., Fahmy, T. M., Edelson, R. L., & Robinson, E. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s66639 · Cited by 113
van der Vlies, A. J., O’Neil, C. P., Hasegawa, U., Hammond, N. A., & Hubbell, J. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9004443 · Cited by 111
Hanniffy, S. B., Carter, A. T., Hitchin, E., & Wells, J. M. (2006) · The Journal of Infectious Diseases · doi:10.1086/509807 · Cited by 110
Principles of innate and adaptive immunity
Janeway, C. A., Travers, P. J., Walport, M. J., & Shlomchik, M. J. (2001) · Cited by 109
Rodríguez‐Limas, W. A., Sekar, K., & Tyo, K. E. J. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.008 · Cited by 106
Chackerian, B., Durfee, M. R., & Schiller, J. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5816 · Cited by 105
In vivo delivery of siRNA to the brain by carbosilane dendrimer
Serramía, M. J., Álvarez, S., Fuentes‐Paniagua, E., Clemente, M. I., Sánchez‐Nieves, J., Gómez, R., de la Mata, J., & Muñoz‐Fernández, M. Á. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.042 · Cited by 105
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Sawaengsak, C., Mori, Y., Yamanishi, K., Mitrevej, A., & Sinchaipanid, N. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-0058-7 · Cited by 105
Wang, T., Zou, M., Jiang, H., Ji, Z., Gao, P. H., & Cheng, G. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.012 · Cited by 103
Alizadeh, D., Zhang, L., Hwang, J., Schluep, T., & Badie, B. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.10.001 · Cited by 103
Gharagozloo, M., Majewski, S. T., & Földvári, M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.003 · Cited by 101
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes
John, A. L. S., Chan, C. Y., Staats, H. F., Leong, K. W., & Abraham, S. N. (2012) · Nature Materials · doi:10.1038/nmat3222 · Cited by 100
Insertion of Nanoparticle Clusters into Vesicle Bilayers
Bonnaud, C., Monnier, C. A., Demurtas, D., Jud, C., Vanhecke, D., Montet, X., Hovius, R., Lattuada, M., Rothen‐Rutishauser, B., & Petri‐Fink, A. (2014) · ACS Nano · doi:10.1021/nn406349z · Cited by 99
Jones, M., Jones, S. A., Riffo‐Vasquez, Y., Spina, D., Hoffman, E., Morgan, A. B., Patel, A., Page, C. P., Forbes, B., & Dailey, L. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.022 · Cited by 99
Bal, S. M., Slütter, B., Verheul, R. J., Bouwstra, J. A., & Jiskoot, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.003 · Cited by 98
Intranasal formulations: promising strategy to deliver vaccines
Riese, P., Sakthivel, P., Trittel, S., & Guzmán, C. A. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.931936 · Cited by 98
Shima, F., Akagi, T., Uto, T., & Akashi, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.064 · Cited by 98
Ochiel, D. O., Fahey, J. V., Ghosh, M., Haddad, S. N., & Wira, C. R. (2008) · Current Women s Health Reviews · doi:10.2174/157340408784246395 · Cited by 95
Solbrig, C., Saucier-Sawyer, J. K., Cody, V., Saltzman, W. M., & Hanlon, D. J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060107e · Cited by 94
Hanson, M. C., Abraham, W. D., Crespo, M. P., Chen, S. H., Liu, H., Szeto, G. L., Kim, M., Reinherz, E. L., & Irvine, D. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2014.12.045 · Cited by 94
Self-citationXu, J., Dai, W.-J., Wang, Z., Chen, B., Li, Z., & Fan, X. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00263-10 · Cited by 94
Nordly, P., Rose, F., Christensen, D., Nielsen, H. M., Andersen, P. L., Agger, E. M., & Foged, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.021 · Cited by 93
Autonomous phagosomal degradation and antigen presentation in dendritic cells
Hoffmann, E., Kotsias, F., Visentin, G., Bruhns, P., Savina, A., & Amigorena, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203912109 · Cited by 92
Fraser, C. C., Altreuter, D. H., Ilyinskii, P. O., Pittet, L. A., LaMothe, R. A., Keegan, M., Johnston, L. P. M., & Kishimoto, T. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.02.024 · Cited by 92
Nakamura, T., Yamazaki, D., Yamauchi, J., & Harashima, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.004 · Cited by 92
Cross‐presentation: dendritic cells and macrophages bite off more than they can chew!
Brode, S., & MacAry, P. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01920.x · Cited by 89
Stefanick, J. F., Ashley, J. D., & Bilgiçer, B. (2013) · ACS Nano · doi:10.1021/nn4033954 · Cited by 88
Wang, C., Liu, P., Zhuang, Y., Li, P., Jiang, B.-L., Pan, H., Liu, L., Cai, L., & Ma, Y. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.081 · Cited by 88
Takano, S., Aramaki, Y., & Tsuchiya, S. (2003) · Pharmaceutical Research · doi:10.1023/a:1024441702398 · Cited by 87
Kinman, L., Brodie, S. J., Tsai, C., Bui, T., Larsen, K., Schmidt, A. M., Anderson, D., Morton, W. R., Hu, S.-L., & Ho, R. J. Y. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200312010-00005 · Cited by 87
Stano, A., Nembrini, C., Swartz, M. A., Hubbell, J. A., & Simeoni, E. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.050 · Cited by 84
Weber, J. S., Boswell, W. D., Smith, J. W., Hersh, E. M., Snively, J., Diaz, M. I., Miles, S., Liu, X., Obrocea, M., Qiu, Z., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181611420 · Cited by 82
Jain, S., Yap, W. T., & Irvine, D. J. (2005) · Biomacromolecules · doi:10.1021/bm0503221 · Cited by 81
Self-citationFifis, T., Mottram, P. L., Bogdanoska, V., Hanley, J. C., & Plebanski, M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.022 · Cited by 81
Vaccine against autoimmune disease: antigen-specific immunotherapy
Anderson, R. P., & Jabrì, B. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.02.004 · Cited by 81
Gungor, B., Yağcı, F. C., Tincer, G., Bayyurt, B., Alpdundar, E., Yildiz, S., Özcan, M., Gürsel, İ., & Gürsel, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007909 · Cited by 79
Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization
Gupta, P. N., & Vyas, S. P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.08.027 · Cited by 78
Hussey, G. S., Schaefer, T. M., & Wira, C. R. (2006) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2006.00381.x · Cited by 77
Systemic immune responses in sheep, induced by a novel nano-bead adjuvant
Scheerlinck, J. Y., Gloster, S. E., Gamvrellis, A., Mottram, P. L., & Plebanski, M. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.009 · Cited by 76
Jain, S., Sharma, R. K., & Vyas, S. P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0003 · Cited by 75
Enhanced B‐cell activation mediated by TLR4 and BCR crosstalk
Minguet, S., Dopfer, E. P., Pollmer, C., Freudenberg, M. A., Galanos, C., Reth, M. G., Huber, M., & Schamel, W. W. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200738094 · Cited by 73
Stano, A., van der Vlies, A. J., Martino, M. M., Swartz, M. A., Hubbell, J. A., & Simeoni, E. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.010 · Cited by 73
Hu, Y., Atukorale, P. U., Lu, J. J.-Q., Moon, J. J., Um, S. H., Cho, E. C., Wang, Y., Chen, J., & Irvine, D. J. (2009) · Biomacromolecules · doi:10.1021/bm801199z · Cited by 72
Self-citationAdjuvant effect of cationic liposomes and CpG depends on administration route
Slütter, B., Bal, S. M., Ding, Z., Jiskoot, W., & Bouwstra, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.007 · Cited by 70
Regulation of Memory Antibody Levels: The Role of Persisting Antigen versus Plasma Cell Life Span
Gatto, D., Martin, S. W., Bessa, J., Pellicioli, E. C., Saudan, P., Hinton, H. J., & Bachmann, M. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.67 · Cited by 69
Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake
Ensign, L. M., Hoen, T. E., Maisel, K., Cone, R. A., & Hanes, J. S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.039 · Cited by 69
Nanomaterial-Induced Autophagy: A New Reversal MDR Tool in Cancer Therapy?
Panzarini, E., & Dini, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500066v · Cited by 67
Taneichi, M., Ishida, H., Kajino, K., Ogasawara, K., Tanaka, Y., Kasai, M., Mori, M., Nishida, M., Yamamura, H., Mizuguchi, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2324 · Cited by 66
Look, M., Saltzman, W. M., Craft, J. E., & Fahmy, T. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.046 · Cited by 66
Dolina, J. S., Sung, S. J., Novobrantseva, T. I., Nguyen, T. M., & Hahn, Y. S. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.63 · Cited by 65
Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection
Perisé-Barrios, A. J., Jiménez, J. L., Domínguez‐Soto, Á., de la Mata, F. J., Corbí, A. L., Gómez, R., & Muñoz‐Fernández, M. Á. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.048 · Cited by 64
Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine
Torres, A. G., Gregory, A. E., Hatcher, C. L., Vinet-Oliphant, H., Morici, L. A., Titball, R. W., & Roy, C. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.11.057 · Cited by 63
Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss
van Vonderen, M. G. A., van Agtmael, M. A., Hassink, E. A. M., Milinkovic, A., Brinkman, K., Geerlings, S. E., Ristola, M. A., van Eeden, A., Danner, S. A., Reiss, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005647 · Cited by 63
Harde, H., Agrawal, A. K., & Jain, S. (2014) · Nanomedicine · doi:10.2217/nnm.13.225 · Cited by 62
Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR)
Minguet, S., Dopfer, E. P., & Schamel, W. W. A. (2010) · International Immunology · doi:10.1093/intimm/dxp129 · Cited by 61
Gilliet, M. F., Kleinhans, M., Lantelme, E., Schadendorf, D., Burg, G., & Nestle, F. O. (2003) · Blood · doi:10.1182/blood-2002-07-2274 · Cited by 59
Wijagkanalan, W., Kawakami, S., Higuchi, Y., Yamashita, F., & Hashida, M. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.016 · Cited by 59
Smith, B. R., Zavaleta, C. L., Rosenberg, J., Tong, R. T., Ramunas, J., Liu, Z., Dai, H., & Gambhir, S. S. (2013) · Nano Today · doi:10.1016/j.nantod.2013.02.004 · Cited by 57
Hanlon, D. J., Aldo, P. B., Devine, L., Alvero, A. B., Engberg, A. K., Edelson, R. L., & Mor, G. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00968.x · Cited by 54
Tanaka, Y., Taneichi, M., Kasai, M., Kakiuchi, T., & Uchida, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015225 · Cited by 52
Yan, S., Gu, W., & Xu, Z. P. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.11.061 · Cited by 51
Barhate, G., Gautam, M., Gairola, S., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.033 · Cited by 51
Adamina, M., Rosenthal, R., Weber, W. P., Frey, D. M., Viehl, C. T., Bolli, M., Huegli, R. W., Jacob, A. L., Heberer, M., Oertli, D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.275 · Cited by 50
Williams, G. R., Fierens, K., Preston, S. G., Lunn, D., Ryśnik, O., Prijck, S. D., Kool, M., Buckley, H. C., Lambrecht, B. N., O'Hare, D. M., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131768 · Cited by 50
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
Harris, J., Sharp, F. A., & Lavelle, E. C. (2010) · European Journal of Immunology · doi:10.1002/eji.200940172 · Cited by 49
Optimizing efficacy of mucosal vaccines
Gebril, A., Alsaadi, M., Acevedo, R., Mullen, A. B., & Ferro, V. A. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.81 · Cited by 48
Enhanced Anti-HIV Efficacy of Indinavir After Inclusion in CD4-Targeted Lipid Nanoparticles
Endsley, A. N., & Ho, R. J. Y. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182653c1f · Cited by 47
Fernandez, É. M., Chang, J., Fontaine, J., Bialecki, E., Rodriguez, F., Werkmeister, E., Krieger, V., Ehret, C., Heurtault, B., Fournel, S., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.068 · Cited by 46
TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces
Chabot, S. M., Chernin, T. S., Shawi, M., Wagner, J. S., Farrant, S. A., Burt, D. S., Cyr, S. L., & Neutra, M. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.029 · Cited by 46
Mittal, A., Schulze, K., Ebensen, T., Weissmann, S. F., Hansen, S., Lehr, C. M., & Guzmán, C. A. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.009 · Cited by 46
Tsuji, K., Hamada, T., Uenaka, A., Wada, H., Sato, E., Isobe, M., Asagoe, K., Yamasaki, O., Shiku, H., Ritter, G., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0478-5 · Cited by 44
Heteromultivalent ligand-decoration for actively targeted nanomedicine
Modery-Pawlowski, C. L., & Gupta, A. S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.047 · Cited by 43
Stylianou, E., Diogo, G. R., Pepponi, I., van Dolleweerd, C. J., Arias, M. A., Locht, C., Rider, C. C., Sibley, L. S., Cutting, S. M., Loxley, A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343887 · Cited by 42
Differential Ability of Surface and Endosomal TLRs To Induce CD8 T Cell Responses In Vivo
Mandraju, R., Murray, S. E., Forman, J., & Pasare, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302244 · Cited by 41
T cell vaccinology: Exploring the known unknowns
Burchill, M. A., Tamburini, B. A. J., Pennock, N. D., White, J. T., Kurche, J. S., & Kedl, R. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.096 · Cited by 38
Arias, M. A., Loxley, A., Eatmon, C., Roey, G. V., Fairhurst, D. A., Mitchnick, M. A., Dash, P. R., Cole, T., Wegmann, F., Sattentau, Q. J., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.084 · Cited by 38
Hasegawa, T., Hirota, K., Tomoda, K., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2007.06.017 · Cited by 35
Mukai, Y., Yoshinaga, T., Yoshikawa, M., Matsuo, K., Yoshikawa, T., Matsuo, K., Niki, K., Yoshioka, Y., Okada, N., & Nakagawa, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001093 · Cited by 35
Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence
Freeling, J. P., & Ho, R. J. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406554111 · Cited by 31
Davis, M. J., & Swanson, J. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310159 · Cited by 30
Fahmy, T. M., Schneck, J. P., & Saltzman, W. M. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.11.010 · Cited by 29
Hajdú, P., Chimote, A. A., Thompson, T. H., Koo, Y., Yun, Y., & Conforti, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.019 · Cited by 28
TLR signalling and phagosome maturation: an alternative viewpoint
Russell, D. G., & Yates, R. M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00920.x · Cited by 27
American Association for Cancer Research Annual Meeting 2016
Coburn, C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30110-3 · Cited by 27
Wang, C., Liu, P., Zhuang, Y., Li, P., Jiang, B.-L., Pan, H., Liu, L., Cai, L., & Ma, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.022 · Cited by 27
Haller, P. K., Cu, Y., Blum, J. S., Appleton, J. A., & Saltzman, W. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100009e · Cited by 26
News & Views in ... Nanomedicine
(2012) · Nanomedicine · doi:10.2217/nnm.12.72 · Cited by 24
Waeckerle‐Men, Y., Bruffaerts, N., Liang, Y., Jurion, F., Sander, P., Kündig, T. M., Huygen, K., & Johansen, P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.034 · Cited by 23
Waeckerle‐Men, Y., Mauracher, A. A., Håkerud, M., Mohanan, D., Kündig, T. M., Høgset, A., & Johansen, P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.02.002 · Cited by 20
Xiao, Y., Zeng, Y., Alexander, E., Mehta, S. B., Joshi, S. B., Buchman, G. W., Volkin, D. B., Middaugh, C. R., & Isaacs, S. N. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.007 · Cited by 19
Influence of Carrier Proteins on the Immunologic Response to Haptenic Antitetrodotoxin Vaccine
Xu, Q.-H., Zhao, X., Cheng, J., Wei, C.-H., Zhang, Q., & Rong, K.-T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060083u · Cited by 12
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
Donahue, N. D., Acar, H., & Wilhelm, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.04.008 · Cited by 944
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b05030 · Cited by 784
Metadata
- Authors
- Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-07-08
- Volume
- 115
- Issue
- 19
- Pages
- 11109-11146
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W994417814
- Cited by
- 763
- References
- 331
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.